These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29188513)

  • 21. Optogenetic Strategies for Vision Restoration.
    Lu Q; Pan ZH
    Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual photosensitivity in mice lacking both rod opsin and cone photoreceptor cyclic nucleotide gated channel 3 alpha subunit.
    Barnard AR; Appleford JM; Sekaran S; Chinthapalli K; Jenkins A; Seeliger M; Biel M; Humphries P; Douglas RH; Wenzel A; Foster RG; Hankins MW; Lucas RJ
    Vis Neurosci; 2004; 21(5):675-83. PubMed ID: 15683556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal optogenetic therapies: clinical criteria for candidacy.
    Jacobson SG; Sumaroka A; Luo X; Cideciyan AV
    Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration.
    Grimm C; Wenzel A; Hafezi F; Yu S; Redmond TM; Remé CE
    Nat Genet; 2000 May; 25(1):63-6. PubMed ID: 10802658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Considerations in repetitive activation of light sensitive ion channels for long-term studies: Channel rhodopsin in the Drosophila model.
    Higgins J; Hermanns C; Malloy C; Cooper RL
    Neurosci Res; 2017 Dec; 125():1-10. PubMed ID: 28728913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy.
    Chan F; Bradley A; Wensel TG; Wilson JH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9109-14. PubMed ID: 15184660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phototoxicities Caused by Continuous Light Exposure Were Not Induced in Retinal Ganglion Cells Transduced by an Optogenetic Gene.
    Tabata K; Sugano E; Hatakeyama A; Watanabe Y; Suzuki T; Ozaki T; Fukuda T; Tomita H
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optogenetics-Mediated Gene Therapy for Retinal Diseases.
    Tomita H; Sugano E
    Adv Exp Med Biol; 2021; 1293():535-543. PubMed ID: 33398840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bipolar cell targeted optogenetic gene therapy restores parallel retinal signaling and high-level vision in the degenerated retina.
    Kralik J; van Wyk M; Stocker N; Kleinlogel S
    Commun Biol; 2022 Oct; 5(1):1116. PubMed ID: 36266533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoring the ON Switch in Blind Retinas: Opto-mGluR6, a Next-Generation, Cell-Tailored Optogenetic Tool.
    van Wyk M; Pielecka-Fortuna J; Löwel S; Kleinlogel S
    PLoS Biol; 2015 May; 13(5):e1002143. PubMed ID: 25950461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Optogenetics: A Therapeutic Option for Advanced Retinal Dystrophies].
    Swiersy A; Klapper SD; Busskamp V
    Klin Monbl Augenheilkd; 2017 Mar; 234(3):335-342. PubMed ID: 28255969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina.
    Sengupta A; Chaffiol A; Macé E; Caplette R; Desrosiers M; Lampič M; Forster V; Marre O; Lin JY; Sahel JA; Picaud S; Dalkara D; Duebel J
    EMBO Mol Med; 2016 Nov; 8(11):1248-1264. PubMed ID: 27679671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
    Han Z; Banworth MJ; Makkia R; Conley SM; Al-Ubaidi MR; Cooper MJ; Naash MI
    FASEB J; 2015 Jun; 29(6):2535-44. PubMed ID: 25713057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Filtration of Short-Wavelength Light Provides Therapeutic Benefit in Retinitis Pigmentosa Caused by a Common Rhodopsin Mutation.
    Orlans HO; Merrill J; Barnard AR; Charbel Issa P; Peirson SN; MacLaren RE
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2733-2742. PubMed ID: 31247114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative characteristics of two anion-channel rhodopsins and prospects of their use in optogenetics.
    Dolgikh DA; Malyshev AY; Roshchin MV; Smirnova GR; Nekrasova OV; Petrovskaya LE; Feldman TB; Balaban PM; Kirpichnikov MP; Ostrovsky MA
    Dokl Biochem Biophys; 2016 Nov; 471(1):440-442. PubMed ID: 28058692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases.
    Yan B; Nirenberg S
    IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders.
    Rutan Woods CT; Makia MS; Lewis TR; Crane R; Zeibak S; Yu P; Kakakhel M; Castillo CM; Arshavsky VY; Naash MI; Al-Ubaidi MR
    Nat Commun; 2024 Jun; 15(1):4756. PubMed ID: 38834544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unfolding retinal dystrophies: a role for molecular chaperones?
    Chapple JP; Grayson C; Hardcastle AJ; Saliba RS; van der Spuy J; Cheetham ME
    Trends Mol Med; 2001 Sep; 7(9):414-21. PubMed ID: 11530337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoring vision to the blind.
    Dowling JE
    Science; 2020 May; 368(6493):827-828. PubMed ID: 32439781
    [No Abstract]   [Full Text] [Related]  

  • 40. Constitutive "light" adaptation in rods from G90D rhodopsin: a mechanism for human congenital nightblindness without rod cell loss.
    Sieving PA; Fowler ML; Bush RA; Machida S; Calvert PD; Green DG; Makino CL; McHenry CL
    J Neurosci; 2001 Aug; 21(15):5449-60. PubMed ID: 11466416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.